Regulatory Q&A Forum

For medical device manufacturers transitioning from a quality system based on the former 21 CFR Part 820 to the new Quality Management System Regulation (QMSR), which incorporates ISO 13485:2016 by re...

When a medical device firm receives an FDA Form 483, the 15-business-day response timeframe is widely considered a critical deadline for preventing the observations from escalating to a Warning Letter...

When a sponsor of a Class II medical device, such as a software as a medical device (SaMD), receives an Additional Information (AI) request for their 510(k) submission, what are the key strategic step...

When a medical device manufacturer discovers that a primary predicate device cited in their cleared 510(k) submission has been subjected to a significant recall, particularly a Class I recall for a de...

When developing a 510(k) submission for a new device that combines features from multiple legally marketed devices—for instance, a novel guidewire that uses the core construction and intended use of P...

When a new medical device integrates features from multiple sources, such as a patient monitor using the core physiological sensing technology of one predicate and the novel software and cybersecurity...

Beyond the basic definitions, how does the fundamental difference between FDA 'clearance' (via 510(k)) and 'approval' (via PMA) translate into distinct strategic and operational plans for a medical de...

When a medical device manufacturer discovers that their chosen predicate for a 510(k) submission has been recalled, what is the strategic framework for determining if the predicate can still be used t...

When a sponsor's 510(k) submission for a device, such as a new orthopedic implant or diagnostic software, receives a 'Refuse to Accept' (RTA) decision, what is a systematic and robust process for craf...

When a new medical device combines distinct technological features from multiple legally marketed predicates—for instance, an imaging catheter incorporating the sensor technology from Predicate A and ...

When a manufacturer identifies multiple potential predicate devices for a 510(k) submission, what is a robust framework for selecting the optimal candidate, especially when no single predicate is a pe...

For a developer of a Software as a Medical Device (SaMD) or wearable technology intended to qualify under the FDA's General Wellness Policy, what constitutes a robust and defensible internal justifica...

For a manufacturer preparing to market a new Class I or simple Class II device in the U.S., how can the broad requirement of "General Controls" be translated into a practical, audit-ready documentatio...

For a manufacturer of a 510(k)-cleared Class II device, what is a comprehensive, step-by-step framework for responding when their primary predicate device is recalled due to a significant safety or pe...

Given that the FDA's eSTAR template is now mandatory for 510(k) submissions, what are the most common eSTAR-specific pitfalls that lead to a Refuse to Accept (RTA) decision, particularly for a Class I...

When developing a 510(k) submission for a device with technological differences from its predicate—such as an infusion pump incorporating updated software and a new user interface—how can sponsors con...

When pursuing a 510(k) using a 'split predicate' strategy, such as for an orthopedic screw combining a novel thread design from one predicate with a unique biocompatible coating from another, what is ...

For sponsors of Class I or low-risk Class II devices, navigating the FDA's General Controls for labeling can present subtle but significant compliance risks. Beyond simply listing the device name, wha...

For a medical device manufacturer, particularly one developing a novel technology like an AI-powered diagnostic software or a new type of wearable sensor, what is a systematic process for determining ...

For a small medical device company or startup, successfully navigating the Medical Device User Fee Amendments (MDUFA) Small Business Determination (SBD) process is often a critical financial step befo...